BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29065704)

  • 1. Diffusion-weighted MRI combined with susceptibility-weighted MRI: added diagnostic value for four common lateral ventricular tumors.
    Yu Y; Zhang H; Xiao Z; She D; Xing Z; Yang X; Cao D
    Acta Radiol; 2018 Aug; 59(8):980-987. PubMed ID: 29065704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative vs. semiquantitative assessment of intratumoral susceptibility signals in patients with different grades of glioma.
    Bhattacharjee R; Gupta RK; Patir R; Vaishya S; Ahlawat S; Singh A
    J Magn Reson Imaging; 2020 Jan; 51(1):225-233. PubMed ID: 31087724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating intracranial solitary fibrous tumor/hemangiopericytoma from meningioma using diffusion-weighted imaging and susceptibility-weighted imaging.
    Chen T; Jiang B; Zheng Y; She D; Zhang H; Xing Z; Cao D
    Neuroradiology; 2020 Feb; 62(2):175-184. PubMed ID: 31673748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of susceptibility- and diffusion-weighted magnetic resonance imaging for grading gliomas.
    Xu J; Xu H; Zhang W; Zheng J
    Exp Ther Med; 2018 Jun; 15(6):5113-5118. PubMed ID: 29805537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of diffusion-weighted imaging combined with apparent diffusion coefficient in differential diagnosis between central neurocytoma and ependymoma.
    Sun PF; Ma L; Ye BQ; Pei YY
    Neuroradiology; 2020 Apr; 62(4):439-445. PubMed ID: 31853589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
    Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
    Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic role of apparent diffusion coefficient combined with intratumoral susceptibility signals in differentiating high-grade gliomas from brain metastases.
    Bozdağ M; Er A; Çinkooğlu A; Ekmekçi S
    Neuroradiol J; 2021 Jun; 34(3):169-179. PubMed ID: 33307971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of Fractal Analysis for the Differentiation of Brain Tumors Using 3-Tesla Magnetic Resonance Susceptibility-Weighted Imaging.
    Di Ieva A; Le Reste PJ; Carsin-Nicol B; Ferre JC; Cusimano MD
    Neurosurgery; 2016 Dec; 79(6):839-846. PubMed ID: 27332779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of susceptibility-weighted imaging to diffusion-weighted imaging in the characterization of parotid gland tumors.
    Jiang JS; Zhu LN; Chen W; Chen L; Su GY; Xu XQ; Wu FY
    Eur Arch Otorhinolaryngol; 2020 Oct; 277(10):2839-2846. PubMed ID: 32328768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral schistosomiasis: diffusion-weighted imaging helps to differentiate from brain glioma and metastasis.
    Huang J; Luo J; Peng J; Yang T; Zheng H; Mao C
    Acta Radiol; 2017 Nov; 58(11):1371-1377. PubMed ID: 28090792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
    Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
    Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
    Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
    Hsu CC; Watkins TW; Kwan GN; Haacke EM
    J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of Diffusion-Weighted Imaging Combined with Susceptibility-Weighted Imaging in Differentiating Benign from Malignant Parotid Gland Lesions.
    Zhang W; Zuo Z; Huang X; Jin G; Su D
    Med Sci Monit; 2018 Jul; 24():4610-4616. PubMed ID: 29972148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility changes in meningiomas influence the apparent diffusion coefficient in diffusion-weighted MRI.
    Schwyzer L; Berberat J; Remonda L; Roelcke U
    J Neuroradiol; 2015 Dec; 42(6):332-7. PubMed ID: 26410100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct measurement of the signal intensity of diffusion-weighted magnetic resonance imaging for preoperative grading and treatment guidance for brain gliomas.
    Wu CC; Guo WY; Chen MH; Ho DM; Hung AS; Chung HW
    J Chin Med Assoc; 2012 Nov; 75(11):581-8. PubMed ID: 23158036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of parotid gland tumours: Application of SWI combined with DWI and DCE-MRI.
    Xu Z; Chen M; Zheng S; Chen S; Xiao J; Hu Z; Lu L; Yang Z; Lin D
    Eur J Radiol; 2022 Jan; 146():110094. PubMed ID: 34906852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.